UniProtKB/Swiss-Prot P46100: Variant p.Val1538Gly

Transcriptional regulator ATRX
Gene: ATRX
Feedback?

Variant information Variant position:

1538 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant:

US The variants are classified into three categories: LP/P, LB/B and US.

LP/P: likely pathogenic or pathogenic.
LB/B: likely benign or benign.
US: uncertain significance

Residue change:

From Valine (V) to Glycine (G) at position 1538 (V1538G, p.Val1538Gly). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties:

Change from medium size and hydrophobic (V) to glycine (G) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score:

-3 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:

Lowest score: -4 (low probability of substitution).
Highest score: 11 (high probability of substitution).

More information can be found on the following page
Variant description:

In ATRX; uncertain significance. Any additional useful information about the variant.

Sequence information Variant position:

1538 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length:

2492 The length of the canonical sequence.
Location on the sequence:

REVIEIEDASPTKCPITTKL V LDEDEETKEPLVQVHRNMVI The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation:

The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         REVIEIEDASPTKCPITTKLVLD-----EDEETKEPLVQVHRNMVI

Chimpanzee                    REVIEIEDASPTKCPITTKLVLD-----EDEETKEPLVQVH

Mouse                         REVIEIEDASPTKCPITTKLVLD-----ENEETKEPLVQVH

Caenorhabditis elegans        EDLTEMLTGTSSQRKLKS-VVLDPDSSTVDEESKKP-VEVH

Drosophila                    SESVEINE-----------LVLD-----FDEESKKALLQVD

Sequence annotation in neighborhood:

The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:

Type: the type of sequence feature.
Positions: endpoints of the sequence feature.
Description: contains additional information about the feature.

Type	Positions	Description
Chain	1 – 2492	Transcriptional regulator ATRX
Modified residue	1527 – 1527	Phosphoserine
Modified residue	1529 – 1529	Phosphothreonine
Alternative sequence	1419 – 2492	Missing. In isoform 6.

Literature citations
ATRX encodes a novel member of the SNF2 family of proteins: mutations point to a common mechanism underlying the ATR-X syndrome.
Picketts D.J.; Higgs D.R.; Bachoo S.; Blake D.J.; Quarrell O.W.J.; Gibbons R.J.;
Hum. Mol. Genet. 5:1899-1907(1996)
Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 2; 3; 4 AND 5); VARIANT SER-1860; VARIANTS ATRX GLY-1538; ARG-1609; ARG-1614; ASN-1650; VAL-2035; HIS-2084; GLN-2131 AND CYS-2163;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.